Recurrent C3 Glomerulonephritis along with BK-Virus-Associated Nephropathy after Kidney Transplantation: A Case Report

被引:1
作者
Lim, Jeong-Hoon [1 ]
Shin, Seong-Won [1 ]
Kim, Mee-Seon [2 ]
Han, Man-Hoon [2 ]
Kim, Yong-Jin [2 ]
Jung, Hee-Yeon [1 ]
Choi, Ji-Young [1 ]
Cho, Jang-Hee [1 ]
Park, Sun-Hee [1 ]
Kim, Yong-Lim [1 ]
Hwang, Deokbi [3 ]
Yun, Woo-Sung [3 ]
Kim, Hyung-Kee [3 ]
Huh, Seung [3 ]
Yoo, Eun Sang [4 ]
Won, Dong Il [5 ]
Kim, Chan-Duck [1 ]
机构
[1] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea
[2] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Pathol, Daegu 41944, South Korea
[3] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Surg, Daegu 41944, South Korea
[4] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Urol, Daegu 41944, South Korea
[5] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Clin Pathol, Daegu 41944, South Korea
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 07期
基金
新加坡国家研究基金会;
关键词
C3; glomerulopathy; glomerulonephritis; kidney transplantation; graft biopsy; BK virus; DENSE DEPOSIT DISEASE; COMPLEMENT;
D O I
10.3390/medicina59071308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C3 glomerulonephritis (C3GN) is a rare cause of end-stage kidney disease and frequently recurrent in allografts following kidney transplantation (KT). Herein, we describe the case of a kidney transplant recipient who developed recurrent C3GN along with BK-virus-associated nephropathy (BKVAN) following KT. A 33-year-old man diagnosed with membranoproliferative glomerulonephritis 17 years ago underwent preemptive KT with a donor kidney from his aunt. Proteinuria gradually increased after 3 months following KT, and graft biopsy was performed 30 months after KT. Histopathological examination revealed recurrent C3GN. The dosages of triple immunosuppressive maintenance therapy agents were increased. Subsequently, serum C3 levels recovered to normal levels. However, at 33 months following KT, the BK viral load increased and graft function gradually deteriorated; a second graft biopsy was performed at 46 months following KT, which revealed BKVAN and decreased C3GN activity. The dosages of immunosuppressive agents were decreased; subsequently, BKVAN improved and graft function was maintained with normal serum C3 levels at 49 months following KT. This case indicates that C3GN is highly prone to recurrence following KT and that immunosuppressive therapy for C3GN increases the risk of BKVAN.
引用
收藏
页数:8
相关论文
共 24 条
[1]   Membranoproliferative glomerulonephritis type II (dense deposit disease):: An update [J].
Appel, GB ;
Cook, HT ;
Hageman, G ;
Jennette, JC ;
Kashgarian, M ;
Kirschfink, M ;
Lambris, JD ;
Lanning, L ;
Lutz, HU ;
Meri, S ;
Rose, NR ;
Salant, DJ ;
Sethi, S ;
Smith, RJH ;
Smoyer, W ;
Tully, HF ;
Tully, SP ;
Walker, P ;
Welsh, M ;
Würzner, R ;
Zipfel, PF .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05) :1392-1403
[2]   Pathogenesis of the C3 glomerulopathies and reclassification of MPGN [J].
Bomback, Andrew S. ;
Appel, Gerald B. .
NATURE REVIEWS NEPHROLOGY, 2012, 8 (11) :634-642
[3]   Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis [J].
Bomback, Andrew S. ;
Smith, Richard J. ;
Barile, Gaetano R. ;
Zhang, Yuzhou ;
Heher, Eliot C. ;
Herlitz, Leal ;
Stokes, M. Barry ;
Markowitz, Glen S. ;
D'Agati, Vivette D. ;
Canetta, Pietro A. ;
Radhakrishnan, Jai ;
Appel, Gerald B. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (05) :748-756
[4]   Update on C3 Glomerulopathy: A Complement-Mediated Disease [J].
Caravaca-Fontan, Fernando ;
Lucientes, Laura ;
Cavero, Teresa ;
Praga, Manuel .
NEPHRON, 2020, 144 (06) :272-280
[5]   Combined C3b and Factor B Autoantibodies and MPGN Type II [J].
Chen, Qian ;
Mueller, Dominik ;
Rudolph, Birgit ;
Hartmann, Andrea ;
Kuwertz-Broeking, Eberhard ;
Wu, Kaiyin ;
Kirschfink, Michael ;
Skerka, Christine ;
Zipfel, Peter F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2340-2342
[6]   Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach [J].
De Vriese, An S. ;
Sethi, Sanjeev ;
Van Praet, Jens ;
Nath, Karl A. ;
Fervenza, Fernando C. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (12) :2917-2929
[7]   Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy [J].
Frangou, Eleni ;
Varnavidou-Nicolaidou, Agathi ;
Petousis, Panayiotis ;
Soloukides, Andreas ;
Theophanous, Elena ;
Savva, Isavella ;
Michael, Nicos ;
Toumasi, Elpida ;
Georgiou, Dora ;
Stylianou, Galatia ;
Mean, Richard ;
Anastasiadou, Natasa ;
Athanasiou, Yiannis ;
Zavros, Michalis ;
Kyriacou, Kyriacos ;
Deltas, Constantinos ;
Hadjianastassiou, Vassilis .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (10) :1780-1788
[8]  
Gonzalez Suarez Maria L, 2020, Med Sci (Basel), V8, DOI 10.3390/medsci8040044
[9]   Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference [J].
Goodship, Timothy H. J. ;
Cook, H. Terence ;
Fakhouri, Fadi ;
Fervenza, Fernando C. ;
Fremeaux-Bacchi, Veronique ;
Kavanagh, David ;
Nester, Carla M. ;
Noris, Marina ;
Pickering, Matthew C. ;
de Cordoba, Santiago Rodriguez ;
Roumenina, Lubka T. ;
Sethi, Sanjeev ;
Smith, Richard J. H. .
KIDNEY INTERNATIONAL, 2017, 91 (03) :539-551
[10]   Excellent outcome after desensitization in high immunologic risk kidney transplantation [J].
Lim, Jeong-Hoon ;
Cho, Jang-Hee ;
Jung, Hee-Yeon ;
Choi, Ji-Young ;
Park, Sun-Hee ;
Kim, Yong-Lim ;
Kim, Hyung-Kee ;
Huh, Seung ;
Yoo, Eun Sang ;
Won, Dong-Il ;
Kim, Chan-Duck .
PLOS ONE, 2019, 14 (09)